Integrated Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Integrated Pharmaceuticals regular Real Value cannot be determined due to lack of data. The prevalent price of Integrated Pharmaceuticals is $0.0. Our model calculates the value of Integrated Pharmaceuticals from evaluating the firm fundamentals such as Price To Earning of (0.06) X, return on equity of -1.91, and Return On Asset of -0.57 as well as inspecting its technical indicators and probability of bankruptcy.
Integrated Pharmaceuticals Total Value Analysis
Integrated Pharmaceuticals is currently anticipated to have valuation of (180.81 K) with market capitalization of 1.79 K, debt of 0, and cash on hands of 180.85 K. The negative valuation of Integrated Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Integrated Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(180.81 K) | 1.79 K | 0 | 180.85 K |
Integrated Pharmaceuticals Investor Information
The company has Price/Earnings To Growth (PEG) ratio of 0.92. Integrated Pharmaceuticals had not issued any dividends in recent years. The entity had 1:4 split on the 20th of September 2000. Based on the key indicators related to Integrated Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Integrated Pharmaceuticals is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Integrated Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Integrated Pharmaceuticals has an asset utilization ratio of 3.2 percent. This connotes that the Company is making $0.032 for each dollar of assets. An increasing asset utilization means that Integrated Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Integrated Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 35.4 K. Net Loss for the year was (1.83 M) with profit before overhead, payroll, taxes, and interest of 23 K.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Integrated Stock
If you are still planning to invest in Integrated Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Pharmaceuticals' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |